文献速递药物不良反应与药物警戒

赖诺普利相关大疱性类天疱疮:老年女性罕见药物不良反应病例报告

Lisinopril-associated bullous pemphigoid in an elderly woman: a case report of a rare adverse drug reaction.
PubMed 文献 · Br J Clin Pharmacol · 2018-08-29

一例87岁高血压、甲状腺功能减退和糖尿病女性,在赖诺普利剂量加倍2个月后出现腹部起源、逐渐扩散的鳞屑性瘙痒性水疱,Naranjo评分7分提示很可能为药物不良反应,皮肤活检确诊为药物诱导的大疱性类天疱疮,为文献中第二例赖诺普利诱导BP及首例剂量-反应变异型报告。

要点

  • 赖诺普利剂量加倍后2个月出现瘙痒性水疱,应考虑药物诱导性大疱性类天疱疮。
  • Naranjo评分7分提示很可能为药物不良反应,皮肤活检可修正诊断。
  • 药物诱导性天疱疮与类天疱疮临床可相似,确诊依赖病理活检。

核心结论

  • 赖诺普利剂量加倍后出现的大疱性类天疱疮被评估为很可能药物不良反应,Naranjo评分为7分。
  • 这是文献中第二例赖诺普利诱导的大疱性类天疱疮,也是首例报告剂量-反应变异型的病例。

研究设计与样本

  • 单例病例报告:87岁女性,有高血压、甲状腺功能减退和糖尿病长期病史。

主要发现

  • lesions初发于腹部,逐渐扩散至下背部、大腿,再至上肢和下肢,病程2个月。
  • 皮损为非疼痛性鳞屑性瘙痒性水疱,基底红斑、表面结痂,仅日晒加重,黏膜不受累。
  • Nikolsky征阳性,但未见明显充盈性大疱。
  • 病史仅显示赖诺普利剂量在皮损出现前2个月加倍,未识别其他潜在环境或药物触发因素。
  • 初始怀疑药物诱导性落叶状天疱疮,皮肤活检将诊断修正为药物诱导性大疱性类天疱疮。

关键数值与推荐

  • Naranjo药物不良反应概率评分为7分。

临床怎么用

  • 对服用赖诺普利等ACEI后出现瘙痒性水疱的老年患者,应警惕药物诱导性大疱性类天疱疮。
  • 详细询问用药剂量变化时间线,并尽早行皮肤活检以明确诊断。
  • 怀疑药物诱导时,应评估停用可疑药物并请皮肤科协作管理。

局限性

  • 单例病例报告,因果关系评估基于Naranjo量表,无法确立普遍性结论。
  • 原文未报告皮损完全消退时间、具体治疗措施及长期随访结局。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

An 87-year-old woman with a long-standing history of hypertension, hypothyroidism and diabetes presented to us with scaly and pruritic vesicles of an erythematous base and crusted surface of 2-month duration. They first appeared on her abdomen and gradually spread to her lower back, thighs, before spreading to her upper and lower limbs. Her lesions were non-painful, aggravated by sun exposure only, and sparing mucous membranes. Nikolsky sign was positive with no discernible fluid-filled bullae. History was remarkable only for a doubling of her Lisinopril dosage 2 months prior to the appearance of her lesions, with no other potential environmental and/or drug triggers recognizable on history taking. In light of the appearance of her lesions after her Lisinopril dose escalation, in the absence of any other discernible triggers, an adverse drug reaction (ADR) was entertained, yielding a corresponding Naranjo ADR probability score of 7. Particularly, drug-induced pemphigus foliaceus was initially suspected given her clinical presentation and the morphology and distribution of her lesions. However, her skin biopsy altered our diagnosis to drug-induced bullous pemphigoid (BP) instead, making this the second case reported to date on Lisinopril-induced BP, and the first to report a dose-response variant of this adverse reaction.

来源:Br J Clin Pharmacol,查看原文。版权归原作者所有。

引用

  1. Ballout RA, Musharrafieh U, Khattar J, et al. Lisinopril-associated bullous pemphigoid in an elderly woman: a case report of a rare adverse drug reaction. Br J Clin Pharmacol. 2018. PMID: 30155951. doi:10.1111/bcp.13737

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。